ADVENTRX: Upcoming News Event and Very Positive Technical Analysis

Print E-mail
By M.E.Garza   
Thursday, 17 December 2009 09:45

Subscribers were alerted to this stock this morning and it traded up nicely. The good news is, it's expected to go higher in the coming days given it's important forward looking news event and undervalued price.

This company just had a presentation at the Lippert/Heilshorn Life Sciences Conference (12/15/09) (look through the slides here) and we issued a breakout alert on it early this morning to our subscribers.

They have a great looking chart and some upcoming news events that will likely see it trading higher in the coming days- especially one that involves the submission of an NDA (new drug application) before the end of the year and two late stage programs that are promising high-return on investment.

ADVENTRX Pharmaceuticals, Inc.

(AMEX:ANX)

Cick to Open Chart

As always, do your own DD. This is an AMEX stock that trades before and after market hours.

 

Disclosure: long ANX





BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
BioMedReports Kamada Announces Significantly Improved Infusion Rate for Glassia®; Celgene Acquires Late-Stage Product for Cr... http://t.co/Fir0Vzekc9
38mreplyretweetfavorite
BioMedReports Healthcare Review: Cesca Therapeutics, RTI Surgical, Amedisys, Celgene, Celgene: U.S. stocks rose, with the St... http://t.co/owMF3qezPA
3hreplyretweetfavorite
navigation
Benzinga.com supporter Seeking Alpha Certified